SeaCrest Wealth Management LLC Purchases Shares of 1,508 Encompass Health Co. (NYSE:EHC)

SeaCrest Wealth Management LLC purchased a new stake in shares of Encompass Health Co. (NYSE:EHCGet Rating) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,508 shares of the company’s stock, valued at approximately $85,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. Baupost Group LLC MA raised its position in Encompass Health by 318.9% during the 1st quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock valued at $213,330,000 after purchasing an additional 2,283,900 shares during the last quarter. Empyrean Capital Partners LP bought a new position in Encompass Health during the 1st quarter valued at approximately $81,506,000. Paradice Investment Management LLC bought a new position in Encompass Health during the 1st quarter valued at approximately $47,388,000. Victory Capital Management Inc. raised its position in Encompass Health by 40.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,146,910 shares of the company’s stock valued at $120,335,000 after purchasing an additional 613,547 shares during the last quarter. Finally, Glenview Capital Management LLC raised its position in Encompass Health by 72.8% during the 1st quarter. Glenview Capital Management LLC now owns 1,285,534 shares of the company’s stock valued at $91,414,000 after purchasing an additional 541,736 shares during the last quarter. Institutional investors own 93.07% of the company’s stock.

Analysts Set New Price Targets

EHC has been the topic of a number of research analyst reports. Stephens reduced their target price on Encompass Health from $60.00 to $58.00 and set an “overweight” rating on the stock in a report on Friday, October 28th. Barclays reduced their target price on Encompass Health from $80.00 to $63.00 and set an “overweight” rating on the stock in a report on Thursday, August 4th. Raymond James upped their target price on Encompass Health from $65.00 to $72.00 and gave the stock a “strong-buy” rating in a report on Friday, October 28th. Deutsche Bank Aktiengesellschaft reduced their target price on Encompass Health from $80.00 to $62.00 in a report on Wednesday, August 3rd. Finally, StockNews.com initiated coverage on Encompass Health in a report on Wednesday, October 12th. They set a “hold” rating on the stock. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $64.13.

Insider Activity at Encompass Health

In other Encompass Health news, Director Greg D. Carmichael acquired 1,830 shares of the stock in a transaction that occurred on Monday, October 31st. The shares were acquired at an average cost of $54.67 per share, with a total value of $100,046.10. Following the transaction, the director now owns 10,546 shares of the company’s stock, valued at approximately $576,549.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.70% of the stock is currently owned by insiders.

Encompass Health Stock Performance

Encompass Health stock opened at $55.32 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 1.59. The company has a market capitalization of $5.52 billion, a P/E ratio of 20.34, a PEG ratio of 2.76 and a beta of 1.06. The stock’s 50 day moving average is $50.77 and its 200 day moving average is $53.89. Encompass Health Co. has a twelve month low of $44.33 and a twelve month high of $74.61.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 17th. Investors of record on Tuesday, January 3rd will be paid a $0.15 dividend. The ex-dividend date is Friday, December 30th. This represents a $0.60 annualized dividend and a dividend yield of 1.08%. Encompass Health’s payout ratio is currently 22.06%.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Stories

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.